Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Next-generation biomaterials to help body heal itself

08.02.2002


The next generation of biomaterials will help the body heal itself by prompting cells to repair their own tissues, scientists report today.



Writing in a review in the journal Science, Professors Larry Hench and Julia Polak of Imperial College, London, highlight the potential of `third generation` biomaterials that activate specific cells and genes of the individual they are implanted into.

Pioneering work by the two authors recently led to the discovery of a family of bone formation genes that can be regulated by bioactive materials. This discovery is already being used to create a new generation of biomaterials for regeneration and repair of tissue.


The authors also signal a new era in biomaterials, calling for research emphasis to shift from replacement to regeneration of tissues.

Professor Hench, discoverer of Bioglass (R) and author of a 1980 Science review of the field, said:

"The advantage of the new approach is that the body`s own genes control the tissue repair process. The result is equivalent to natural tissues in that the new structure is living and adaptable to the physiological environment. It is the scientific basis for us to design a new generation of gene-activating biomaterials tailored for specific patients and disease states."

In the last two years a group at Imperial College Tissue Engineering Centre headed by Professor Polak has analysed how human cells behave when they are attached to scaffolds of a specific bioactive material.

They demonstrated that key genes of bone cells involved in bone formation are activated when a bioactive material designed and configured for the purpose of bone formation is brought together with it. At the same time other genes, normally activated when fat or other tissues are formed, were down regulated.

"In the future we may only need to implant the carefully calculated chemical ingredients of the biomaterial, rather than a `finished` biomaterial itself, in order to repair tissue," said Professor Hench.

"By designing these very specific molecular scaffolds for repair of tissues and using minimally invasive surgery to implant them, this technique could have a major clinical application."

"Perhaps of even more importance is the possibility that bioactive stimuli can be used to activate genes in a preventative treatment to maintain the health of tissues as they age," he said.

Their review tracks the development of the field from the 1960s to the present day, in a special edition of the journal on the `Bionic Human.`

In the 1960`s and 1970`s, the first generation of biomaterials was developed for use inside the human body. A key feature of these biomaterials is their biological inertness, which minimises the body`s response to the foreign body. The authors estimate that tens of millions of individuals have had their quality of life enhanced for 5 to 25 years through such implants.

In 1984 a major shift began with a second generation of materials that become activated in a controlled way when implanted in the body. `Bioactive` materials such as glasses, ceramics and composites have since been used in a variety of orthopaedic and dental applications. `Resorbable` biomaterials that are slowly broken down and replaced by regenerating tissues appeared at the same time.

However the authors state that survivability rates of skeletal prostheses and artificial heart valves show that a third to half of prostheses fail within 10-25 years, meaning that many patients require revision surgery.

The article is one of 9 reports on the topic `Bodybuilding: The Bionic Human`, covered in Science this week.


For more information please contact:

Professor Larry Hench
Department of Materials and Imperial College Tissue Engineering Centre
Tel: +44 (0)20 7594 6745
Email: l.hench@ic.ac.uk

Professor Julia Polak
Imperial College Tissue Engineering Centre
Tel: +44 (0)20 8237 2670
Email: julia.polak@ic.ac.uk

Tom Miller
Imperial College Press Office
Tel: +44 (0)20 7594 6704
Mob: +44 (0)7803 886248
Email: t.miller@ic.ac.uk

Tom Miller | alphagalileo

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>